title: Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion.
abstract: OBJECTIVE
  Aminophylline and ceftazidime are sometimes used concurrently in patients with respiratory disorders. Parenteral aminophylline usually is administered as a constant infusion, and ceftazidime is given intermittently or less commonly as a constant infusion. We evaluated the stability and compatibility of the two drugs when aminophylline is given as a constant intravenous infusion and ceftazidime is administered simultaneously either through a y-site (piggyback method) or as a continuous infusion (constant infusion method).
  
  
  METHODS
  The chemical stability of intravenous aminophylline and ceftazidime in dextrose 5% and NaCl 0.9% for both methods was studied. Three different formulations of ceftazidime from the same manufacturer were studied (minibag using reconstituted ceftazidime, premixed minibag, and ceftazidime arginine). For the piggyback and constant infusion methods, samples were collected at 0, 1, and 2 hours; and 0, 6, and 24 hours, respectively. All experiments were conducted in triplicate. Samples were analyzed in duplicate by a stability-indicating HPLC assay method.
  
  
  METHODS
  Ceftazidime and aminophylline were considered stable if concentrations remained above 90 percent of the original concentrations over the time periods studied.
  
  
  RESULTS
  Ceftazidime was determined to be compatible with aminophylline in the piggyback method. In contrast, when aminophylline and ceftazidime were admixed in the same intravenous container (constant infusion method), the two drugs were not stable.
  
  
  CONCLUSIONS
  These data indicate that aminophylline and ceftazidime admixtures are incompatible when prepared in the same intravenous container, which may occur if both are given as a constant infusion. The two drugs are compatible when the ceftazidime is piggybacked into a primary intravenous set in which aminophylline is administered as a constant infusion.
authors.affiliation: Department of Pharmacy, Duke University Medical Center, Durham, NC 27710.
authors.forename: R A
authors.initials: RA
authors.lastname: Pleasants
authors.forename: L M
authors.initials: LM
authors.lastname: Vaughan
authors.forename: D M
authors.initials: DM
authors.lastname: Williams
authors.forename: J L
authors.initials: JL
authors.lastname: Fox
mesh_terms: D000628:Aminophylline / Q000008:administration & dosage / Q000737:chemistry*; D002442:Ceftazidime / Q000008:administration & dosage / Q000737:chemistry*; D004344:Drug Incompatibility; D004359:Drug Therapy, Combination; D007262:Infusions, Intravenous
chemical_list: D000628:Aminophylline; D002442:Ceftazidime